TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/27/24 16:30 | 12/24/24 | EWTX | Edgewise Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Semigran Marc | CO | O | Chief De | M.d | 266 | 8.94 | 0 | 30 | 7 | D | |||||||||||||||
12/27/24 16:30 | 12/24/24 | EWTX | Edgewise Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Semigran Marc | CO | O | Chief De | S.d | -882 | 29.69 | 0 | -30 | -82 | 7 | D | ||||||||||||||
1/3/19 21:57 | 1/1/19 | MYOK | Myokardia Inc | DE | Health | Drug | Pharmaceutical Preparations | Semigran Marc | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 1 | 439 | 2 | D | ||||||||||||||
9/6/18 17:00 | 9/4/18 | MYOK | Myokardia Inc | DE | Health | Drug | Pharmaceutical Preparations | Semigran Marc | CA | O | Chief Me | M.dm | 718 | 15.95 | 0 | 45 | 0 | D | |||||||||||||||
9/6/18 17:00 | 9/4/18 | MYOK | Myokardia Inc | DE | Health | Drug | Pharmaceutical Preparations | Semigran Marc | CA | O | Chief Me | S.dm | -2,679 | 59.53 | 0 | -45 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |